Figure 1

The effect of TET1 expression on glioma patient survival. (A) Kaplan-Meier curves for glioma patients with TET1 tumor expression at levels greater than the median (red) and less than the median (blue). (B) Kaplan-Meier curves for each for TET1 higher/lower than median by disease type, age and gender. (C) Predicted hazard as a function of Log TET1 expression for 10 cross-validated TET1 only models.